v3.26.1
Note 9 - Investment in Conduit Pharmaceuticals (Details Textual)
1 Months Ended
May 19, 2025
Jan. 22, 2025
May 31, 2025
USD ($)
Mar. 31, 2026
USD ($)
shares
Dec. 31, 2025
USD ($)
Jan. 24, 2025
$ / shares
shares
Dec. 31, 2024
USD ($)
shares
Equity Securities, FV-NI | $       $ 5,885 $ 3,900    
Conduit Pharmaceuticals Inc [Member]              
Equity Securities, FV-NI | $       $ 5,885      
Conduit Pharmaceuticals Inc [Member] | Private Warrants [Member]              
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares       540,000      
Reverse Stock Split [Member]              
Stockholders' Equity Note, Stock Split, Conversion Ratio 10 100          
Conduit Pharmaceuticals Inc [Member]              
Investment Owned, Balance, Shares (in shares) | shares           29,445 2,944,514
Equity Securities, FV-NI | $       $ 5,885 $ 3,900   $ 3,900
Conduit Pharmaceuticals Inc [Member] | CDT Common Stock [Member]              
Investment Owned, Fraction Share Payout (in dollars per share) | $ / shares           $ 0.63  
Proceeds from Sale, Maturity and Collection of Investments | $     $ 13,990        
Conduit Pharmaceuticals Inc [Member] | CDTTW Warrants [Member]              
Investment Owned, Balance, Shares (in shares) | shares       709,000     709,000
Conduit Pharmaceuticals Inc [Member] | Private Warrants [Member]              
Investment Owned, Balance, Shares (in shares) | shares             540,000